Global Vision. Local Expertise.
Trusted Partners

We drive cross-border M&A, licensing, partnerships, and strategic growth for the healthcare sector — where strategy, expertise, and insight connect

Our Services

About CHC Capital Partners

Boutique healthcare advisory firm delivering M&A, licensing, and strategic advisory across global healthcare markets

Healthcare-Focused, Trusted Partners

CHC Capital Partners focuses exclusively on healthcare M&A, biotech licensing and partnerships, and strategic advisory for the global healthcare industry

We bring specialized expertise across pharma, biotech, medtech, IVD, consumer health, healthtech, and healthcare services, with deep knowledge of regulatory environments, market dynamics, and the unique valuation challenges of healthcare
Senior partners lead every engagement from pitch to close, applying decades of sector-specific experience
With a proven track record across Europe, North America, and Asia-Pacific, we partner with pharmaceutical companies, biotech innovators, medtech firms, and healthcare investors to execute complex, high-value transactions that deliver lasting impact

15+

Years Healthcare Experience

50+

Healthcare Transactions

$10B+

Healthcare Transaction Value

Healthcare Markets

Our Services

Specialized advisory services for the global healthcare industry

Mergers & Acquisitions

End-to-end M&A advisory for healthcare companies, including buy-side and sell-side mandates, cross-border transactions, and strategic partnerships

Licensing & Partnerships

Bridging parties, facilitating introductions and negotiations, and advising on licensing agreements, co-development partnerships, and commercial collaborations for biotech and pharmaceutical assets

Strategic Advisory

Market entry strategies, portfolio optimization, growth planning, and transaction support for healthcare companies across all sectors

Financial Advisory

Valuation analysis, financial modeling, and transaction structuring tailored to healthcare industry dynamics. (Note: excluding regulated securities activities)

Valuation & Due Diligence

Healthcare-specific company and asset valuation, commercial due diligence, and market analysis for transactions and strategic decision-making

Joint Ventures

Structuring and advising on cross-border joint ventures and strategic alliances in regulated healthcare markets

Healthcare Industry Focus

Deep sector expertise across the healthcare landscape

Pharmaceuticals

M&A, licensing, and strategic advisory for companies from Big Pharma to specialty pharma

Biotechnology

Partnerships, licensing, and M&A for biotech companies across therapeutic areas and development stages

MedTech

M&A and strategic advisory for medical device, diagnostic, and digital health companies

IVD

Expertise in In Vitro Diagnostics, including molecular diagnostics, point-of-care testing, and lab equipment

Consumer Health

Advisory for OTC, nutraceutical, wellness, and personal care companies

Healthcare Services

Advisory for providers, CROs, CDMOs, and other healthcare service companies

Disclaimer: CHC Capital Partners provides corporate, strategic, and financial advisory services exclusively. We do not provide regulated investment advice, securities dealing, or asset management services as defined by the UK Financial Conduct Authority (FCA) or the Hong Kong Securities and Futures Commission (SFC).

Our People

Senior partners with top-tier global healthcare experience

Senior-led, partner-focused

Proven Leadership: Former executives from top-tier investment banks, MBB consulting firms, and global healthcare corporations
Deep Experience: An average of 15+ years in healthcare advisory, investment, and industry leadership
Global Expertise: Multilingual professionals with in-depth knowledge of cross-border healthcare markets
Powerful Network: Strong international connections with Pharma and MedTech executives, biotech and healthtech entrepreneurs, healthcare service providers, and leading investors

Learn More

Contact Us

For confidential discussions please reach out to schedule a director-level call

Send us an email

We'll respond within 48 hours

+44 20 4577 0383

London, UK

Our locations

London, New York, Hong Kong